Sanofi says Dupixent could be a $10 billion drug, aims to sell Cialis and Tamiflu over the counter

The new CEO of Sanofi (SNY), the French drug giant, believes that its drug Dupixent, for the treatment of severe rashes and asthma, could surpass $10 billion in annual sales.